Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
13
×
raleigh-durham blog main
13
×
venture capital
13
×
boston blog main
new york blog main
san diego blog main
san francisco blog main
seattle blog main
biotech
detroit blog main
indiana blog main
life sciences
national top stories
texas blog main
wisconsin blog main
boston top stories
boulder/denver blog main
national
raleigh-durham top stories
texas top stories
detroit top stories
new york top stories
san diego top stories
san francisco top stories
seattle top stories
vc
wisconsin top stories
boulder/denver top stories
indiana top stories
startups
cancer
fda
medical devices
ipo
novartis
biogen
celgene
clinical trials
deals
gene editing
What
bio
roundup
new
developing
investors
ipo
life
million
patients
science
covid
fda
medicines
plans
sciences
talk
years
abbvie’s
acquisitions
activity
advantages
ahead
allogene
announced
approvals
asco
attributes
bar
barbecuing
becker
beta
better
billions
biogen
bionics
biopharma
blood
boston’s
branded
brings
Language
unset
Current search:
" national blog main "
×
" venture capital "
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
In Boston’s Shadow, Rhode Island Fights for Life Science Jobs, Respect